Abstract
ObjectivesTo systematically evaluate the efficacy and safety of anaplastic lymphoma kinase (ALK) inhibitors in ALK-rearranged positive non-small cell lung cancer (NSCLC) with brain metastases, and update the overall survival (OS)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have